Pentec Health, a leader in patient specific and sterile compounding, has been recognized as one of the Philadelphia regions top 100 fastest-growing, privately-held companies. The 2017 award marks Pentec’s inclusion on the Philadelphia 100® for the seventh time in the past eight years. The Philadelphia 100® is considered to be the standard of excellence for entrepreneurial success in the region and is awarded by The Wharton Small Business Development Center at the Wharton School of the University of Pennsylvania, Entrepreneurs’ Forum of Greater Philadelphia and Philadelphia Media Network, publisher of The Philadelphia Inquirer, Daily News, and Philly.com.
“Our strength is in our engaged and brilliant workforce. They are committed to helping the company succeed by providing the best products and services for patients,” said Joseph Cosgrove, Chairman, President and CEO of Pentec Health. Mr. Cosgrove also stated, “The strategic focus on innovation is an integral part of our company’s unique entrepreneurial fiber and has been the catalyst which has led to Pentec Health’s long term sustainable growth.”
The 29th Annual Philadelphia 100® Awards Ceremony will be held Thursday, October 26, 2017, revealing the rankings and growth rates of the 100 honored companies. A complete alphabetical list of the winning companies with rankings will be posted on the Philadelphia100.com website by midnight of October 26th.
For almost 40 years, Pentec Health has been an industry leader in providing patient-specific, compounded sterile medications. Pentec Health’s formulations are used for administration in dialysis centers, as well as providing in-home Targeted Drug Delivery through nursing services and complex pharmaceutical products to patients who require access outside of a hospital setting. Pentec Health has built a tradition of exceptional patient care by committing to quality, safety, and innovation. We aim to be the provider of choice for outsourced products, sterile preparations, and services in the healthcare marketplace. For more information, please visit pentechealth.com.
The Philadelphia 100® is a joint project of the Wharton Small Business Development Center, the Entrepreneurs’ Forum of Greater Philadelphia, and the Philadelphia Business Journal. The rankings are based on verified revenue growth, and the program’s evaluation has been carefully managed to ensure its fairness and integrity. As a result, ranking as a Philadelphia 100® company is highly competitive. For more on The Philadelphia 100®, please visit http://www.philadelphia100.com.
ContactPentec Health, Inc.Shetal Vyas484-480-2279
Proudly Quality AccreditedNational Quality ApprovalThe Joint Commission
Accredited Practice TransitionProgram With DistinctionAmerican Nurses Credentialing Center